“Innovation Act Stalled: What Now?”
Intellectual Property Magazine 09/01/15 By Jessica L. Lewis
Below is an excerpt:
Whether viewed from the perspective of in-house patent counsel, law firm litigation teams or patent prosecution specialists, the current US patent system is rife with uncertainty. This is respect to the issuance and enforcement of software and biotechnology patents, the commercial value of patent assets, how to attract and retain the interest of investors and licensees and how best to budget for prosecution and litigation costs. While some unpredictability stems from recent paradigm-shifting decisions from the Supreme Court and revised USC § 101 guidance from the US Patent and Trademark Office, post-grant proceedings before the Patent Trial and Appeal Board (PTAB) are also relatively new and a handful of patent reform proposals gained significant momentum in the current congressional session.
Originally published in Intellectual Property Magazine, September, 2015